238 related articles for article (PubMed ID: 18456347)
1. Molecular cloning and characterization of Plasmodium falciparum transketolase.
Joshi S; Singh AR; Kumar A; Misra PC; Siddiqi MI; Saxena JK
Mol Biochem Parasitol; 2008 Jul; 160(1):32-41. PubMed ID: 18456347
[TBL] [Abstract][Full Text] [Related]
2. Characterization and localization of Plasmodium falciparum homolog of prokaryotic ClpQ/HslV protease.
Ramasamy G; Gupta D; Mohmmed A; Chauhan VS
Mol Biochem Parasitol; 2007 Apr; 152(2):139-48. PubMed ID: 17270290
[TBL] [Abstract][Full Text] [Related]
3. A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization.
Krungkrai SR; DelFraino BJ; Smiley JA; Prapunwattana P; Mitamura T; Horii T; Krungkrai J
Biochemistry; 2005 Feb; 44(5):1643-52. PubMed ID: 15683248
[TBL] [Abstract][Full Text] [Related]
4. Human malaria parasite orotate phosphoribosyltransferase: functional expression, characterization of kinetic reaction mechanism and inhibition profile.
Krungkrai SR; Aoki S; Palacpac NM; Sato D; Mitamura T; Krungkrai J; Horii T
Mol Biochem Parasitol; 2004 Apr; 134(2):245-55. PubMed ID: 15003844
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase.
Kandeel M; Kitade Y
J Biochem; 2008 Aug; 144(2):245-50. PubMed ID: 18477629
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase of the malarial parasite Plasmodium falciparum: characterization of a potential drug target.
Harwaldt P; Rahlfs S; Becker K
Biol Chem; 2002 May; 383(5):821-30. PubMed ID: 12108547
[TBL] [Abstract][Full Text] [Related]
7. Structure, evolution, and inhibitor interaction of S-adenosyl-L-homocysteine hydrolase from Plasmodium falciparum.
Bujnicki JM; Prigge ST; Caridha D; Chiang PK
Proteins; 2003 Sep; 52(4):624-32. PubMed ID: 12910461
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from Plasmodium falciparum.
Chan M; Sim TS
Biochem Biophys Res Commun; 2005 Jan; 326(1):188-96. PubMed ID: 15567170
[TBL] [Abstract][Full Text] [Related]
9. Molecular-docking study of malaria drug target enzyme transketolase in Plasmodium falciparum 3D7 portends the novel approach to its treatment.
Hasan MA; Mazumder MH; Chowdhury AS; Datta A; Khan MA
Source Code Biol Med; 2015; 10():7. PubMed ID: 26089981
[TBL] [Abstract][Full Text] [Related]
10. Characterization of coproporphyrinogen III oxidase in Plasmodium falciparum cytosol.
Nagaraj VA; Prasad D; Arumugam R; Rangarajan PN; Padmanaban G
Parasitol Int; 2010 Jun; 59(2):121-7. PubMed ID: 20006984
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterparts.
Akoachere M; Iozef R; Rahlfs S; Deponte M; Mannervik B; Creighton DJ; Schirmer H; Becker K
Biol Chem; 2005 Jan; 386(1):41-52. PubMed ID: 15843146
[TBL] [Abstract][Full Text] [Related]
12. Homology modeling of human transketolase: description of critical sites useful for drug design and study of the cofactor binding mode.
Obiol-Pardo C; Rubio-Martinez J
J Mol Graph Model; 2009 Feb; 27(6):723-34. PubMed ID: 19111488
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the cellular and biochemical properties of Plasmodium falciparum choline and ethanolamine kinases.
Alberge B; Gannoun-Zaki L; Bascunana C; Tran van Ba C; Vial H; Cerdan R
Biochem J; 2009 Dec; 425(1):149-58. PubMed ID: 19845508
[TBL] [Abstract][Full Text] [Related]
14. Localisation of Plasmodium falciparum uroporphyrinogen III decarboxylase of the heme-biosynthetic pathway in the apicoplast and characterisation of its catalytic properties.
Nagaraj VA; Arumugam R; Chandra NR; Prasad D; Rangarajan PN; Padmanaban G
Int J Parasitol; 2009 Apr; 39(5):559-68. PubMed ID: 19041871
[TBL] [Abstract][Full Text] [Related]
15. Homology modeling and mutagenesis analyses of Plasmodium falciparum falcipain 2A: implications for rational drug design.
Goh LL; Sim TS
Biochem Biophys Res Commun; 2004 Oct; 323(2):565-72. PubMed ID: 15369788
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of the gene encoding cytidine triphosphate synthetase from Plasmodium falciparum which contains two novel sequences that are potential antimalarial targets.
Yuan P; Hendriks EF; Fernandez HR; O'Sullivan WJ; Stewart TS
Mol Biochem Parasitol; 2005 Oct; 143(2):200-8. PubMed ID: 16051382
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of recombinant Plasmodium falciparum adenylosuccinate synthetase expressed in Escherichia coli.
Jayalakshmi R; Sumathy K; Balaram H
Protein Expr Purif; 2002 Jun; 25(1):65-72. PubMed ID: 12071700
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum: enhanced soluble expression, purification and biochemical characterization of lactate dehydrogenase.
Berwal R; Gopalan N; Chandel K; Prasad GB; Prakash S
Exp Parasitol; 2008 Oct; 120(2):135-41. PubMed ID: 18619439
[TBL] [Abstract][Full Text] [Related]
19. Structural model of the Plasmodium falciparum thioredoxin reductase:a novel target for antimalarial drugs.
Banerjee AK; Arora N; Murty US
J Vector Borne Dis; 2009 Sep; 46(3):171-83. PubMed ID: 19724080
[TBL] [Abstract][Full Text] [Related]
20. Identification, expression, modeled structure and serological characterization of Plasmodium vivax histone 2B.
Rawat DS; Sharma I; Jalah R; Lomash S; Kothekar V; Pasha ST; Sharma YD
Gene; 2004 Aug; 337():25-35. PubMed ID: 15276199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
